US 12,485,172 · Application 19/088,718 · Granted Dec 2, 2025
US 12,485,172
Pharmaceutical products and stable liquid compositions of il-17 antibodies
Estimated expiration
December 21, 2035
9y 84d remaining
- Could not fetch continuity data for application PCTIB2015059836: Resource not found (404)
Earliest effective filing
Dec 21, 2015
+ 20 years
Dec 21, 2035
PTA +0d
Dec 21, 2035
TD applied
Dec 21, 2035
Final
Dec 21, 2035
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- March 24, 2025
- Earliest effective filing
- December 21, 2015
- Issue date
- December 2, 2025
- PTA
- 0 days
- Base expiry (before PTA)
- December 21, 2035
December 21, 2015 + 20 years = December 21, 2035
- Continuation of application 18/481,213, filed Oct 4, 2023, issued as US 12,599,664
- Divisional of application 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
- National stage entry of application PCTIB2015059836, filed Dec 21, 2015
- National stage entry of application PCTIB2015059836, filed Dec 21, 2015
- Divisional of application 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
- National stage entry of application PCTIB2015059836, filed Dec 21, 2015
- PRO62/095,210 — Provisional — not used for base term
- PRO62/095,210 — Provisional — not used for base term
- PRO62/095,210 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to December 21, 2035
US 12,485,172· Application 19/088,718(from application 19/088,718)Capping patent
Pharmaceutical products and stable liquid compositions of il-17 antibodies
- Filing date
- Mar 24, 2025
- Earliest effective filing
- Dec 21, 2015
- Issue date
- Dec 2, 2025
- PTA
- 0 days
- Calculated expiration
- Dec 21, 2035
Continuation of 18/481,213, filed Oct 4, 2023, issued as US 12,599,664
Divisional of 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
National stage entry of PCTIB2015059836, filed Dec 21, 2015
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Divisional of 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Dec 21, 2015 + 20y = Dec 21, 2035
US 12,599,664· Application 18/481,213(from application 18/481,213)
Pharmaceutical products and stable liquid compositions of il-17 antibodies
- Filing date
- Oct 4, 2023
- Earliest effective filing
- Dec 21, 2015
- Issue date
- Apr 14, 2026
- PTA
- +12 days
- Calculated expiration
- Jan 2, 2036
Divisional of 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
National stage entry of PCTIB2015059836, filed Dec 21, 2015
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Dec 21, 2015 + 20y + 12d PTA = Jan 2, 2036
US 12,485,173· Application 19/088,722(from application 19/088,722)
Pharmaceutical products and stable liquid compositions of il-17 antibodies
- Filing date
- Mar 24, 2025
- Earliest effective filing
- Dec 21, 2015
- Issue date
- Dec 2, 2025
- PTA
- 0 days
- Calculated expiration
- Dec 21, 2035
Continuation of 18/481,213, filed Oct 4, 2023, issued as US 12,599,664
Divisional of 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
National stage entry of PCTIB2015059836, filed Dec 21, 2015
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Divisional of 15/538,257, filed Jun 21, 2017, issued as US 11,801,300
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Dec 21, 2015 + 20y = Dec 21, 2035
US 11,801,300· Application 15/538,257
Pharmaceutical products and stable liquid compositions of il-17 antibodies
- Filing date
- Jun 21, 2017
- Earliest effective filing
- Dec 21, 2015
- Issue date
- Oct 31, 2023
- PTA
- 0 days
- Calculated expiration
- Dec 21, 2035
National stage entry of PCTIB2015059836, filed Dec 21, 2015
Dec 21, 2015 + 20y = Dec 21, 2035
Notes (1)
- [TD_DOCS_TRUNCATED] Found 5 filed TD documents; parsing first 3 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 19/088,718 · US 12,485,172
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,485,172: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12485172Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.